Topic: Why see a uveal melanoma oncologist and how to talk with your oncologist about clinical trials?
A Cure in Sight is joined by Dr. Justin Moser, a medical oncologist in the Phoenix, Arizona area.
He shares helpful tips to keep in mind when having discussions with a medical oncologist, and why it’s vital for patients to be seen and under the watch and care of a medical oncologist either familiar with uveal melanoma protocols for scans and care, or someone who is willing to learn from another oncologist in the field.
Dr. Moser explains some of the process behind selecting a clinical trial for a patient experiencing metastatic spread, and how you as a patient can ask for less known trials that are not entirely ready for Uveal melanoma yet, but are planned to have a few spots for uveal melanoma spread.
Thank you Dr. Moser for your time and research!
Dr. Justin Moser is a medical oncologist and hematologist and associate clinical investigator at HonorHealth Research Institute, clinical assistant professor at the University of Arizona College of Medicine – Phoenix, and an adjunct faculty member at the Translational Genomics Research Institute (TGen). He is an expert in the treatment of melanoma and other skin cancers and co-leads the Cutaneous Oncology Tumor Site Strategy Group for HonorHealth.
Dr. Moser graduated from the University of Iowa Carver College of Medicine with distinctions in research and teaching. He completed his Internal Medicine Residency at Mayo Clinic in Rochester, Minnesota and his fellowship in Hematology/Oncology at the Huntsman Cancer Institute. He has strong passion for developing new treatments for patients with cancer and was a visiting fellow at the Cancer Therapy Evaluation Program at the National Cancer Institute.
Dr. Moser’s has a special focus on patients with rare skin cancers, such as uveal melanoma, squamous cell carcinoma, Merkle cell carcinoma and basal cell carcinoma, as patients with these cancers often have fewer treatment options available.
For more information on the HonorHealth Research Institute Melanoma and Skin Cancer Clinic or to make an appointment please call our Nurse Navigators at 480-323-1364 or email clinicaltrials@honorhealth.com.
Be sure to follow us on Instagram @acureinsight, for more stories, tips, and ideas to help you navigate this journey with OM!
*A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more! Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure. LINK TO PAYPAL OR VENMO
This podcast was hosted by Danet Peterson and produced by Agora Media.
E50: The One-Eyed Cooking Show with Alec MacKenzie
Eye Believe 2022: D2T2 ”Healing with your story”
Eye Believe 2022: D2T2 ”What we can expect of our friends after an OM diagnosis”
Eye Believe 2022: D2T2 ”Low Vision Resources”
Eye Believe 2022: D2T2 ”Navigating Insurance” with Triage Cancer
Eye Believe 2022: Patient Mini Interview Panel
Eye Believe 2022: D2T1 ”Your Eye After Treatment”
Eye Believe 2022: D2T1 ”Standards of Care for Uveal Melanoma”
Eye Believe 2022: D2T1 ”KIMMTRAK approved; NOW WHAT?”
Eye Believe 2022: D2T1 Ocular Melanoma Met’s Explained
Eye Believe 2022-Welcome with Dr. Reichstein
E48: Shared decision Making with Patients with Dr. Patel
E45: Radical Acceptance in an OM Diagnosis with Allie, age 26
Eye Believe 2022: D1 ”Understanding a registry?”
E47: Managing METS & Clinical Trials with Dr. Carvajal
E46: The Importance of Self-Compassion with Dr. Kristin Markell
Eye Believe 2022:D1 ”Art and Music Therapy”
Eye Believe 2022 D1:”Talking to children about Cancer”
Eye Believe 2022: D1 ”What to do in the waiting room”
E44: NED to METS in 3 month span with Kat McCrea
Create your
podcast in
minutes
It is Free
Good Mood Revolution
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
Precision Medicine Forum Podcast
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive